180 results
Page 4 of 9
6-K
EX-99.1
elp cxe3t0b
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.2
35lqs80980xqrm
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
gyeqpoxjf
23 Apr 21
Current report (foreign)
6:05am
6-K
EX-99.1
9wkzy5mp lgm3ckr
25 Mar 21
Galapagos appoints Bart Filius as President and Chief Operating Officer
6:00am
6-K
EX-99.1
mj2ddk5l2 ynfj
4 Mar 21
GALAPAGOS REPORTS PRIMARY ENDPOINT FOR THE ONGOING FILGOTINIB MANTA AND MANTA-RAy SAFETY STUDIES
6:05am
6-K
EX-99.1
7q716ttxpkwvhwb0ob0f
19 Feb 21
Pipeline and capital for growth
6:00am
6-K
EX-99.1
58hb nlmo
10 Feb 21
Current report (foreign)
11:31am
6-K
EX-99.1
s1s5dm7i tbuvfho1e
21 Jan 21
Current report (foreign)
7:49am
6-K
EX-99.1
u309cl4m
6 Jan 21
Galapagos to present at 39th Annual J.P. Morgan Healthcare Conference
9:57am
6-K
EX-99.1
lkx19a32bzgwgy5btwlm
15 Dec 20
Current report (foreign)
4:55pm
6-K
EX-99.1
g8gf9rnlcadm0v
3 Dec 20
Galapagos announces first dosing in MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
4:34pm
6-K
EX-99.1
8a5bap ai
30 Nov 20
Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial
5:10pm
6-K
EX-99.1
9ujnp50nsst2a101kjq
10 Nov 20
Current report (foreign)
6:05am
6-K
EX-99.2
oborl6vhk39ny9qtfhm
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
EX-99.1
0oxbnrd10far4rj6tfqw
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
EX-99.1
zsg0ghm9wxlj9frzobvf
6 Nov 20
Current report (foreign)
10:06am
6-K
EX-99.1
if3la m3id3jll
3 Nov 20
Current report (foreign)
6:00am
6-K
EX-99.1
3u2esorjxb6
27 Oct 20
Current report (foreign)
12:13pm
6-K
EX-99.1
1axoh1mknf v3efy7
15 Oct 20
Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
5:27pm